Search or choose
Find the right test or package.
The ER, PR, c erb B2 (Her2) by IHC test is a key panel used to evaluate breast cancer. It checks for three important proteins in tumor tissue such as Estrogen Receptor (ER), Progesterone Receptor (PR), and Her2 (c-erbB2) using the immunohistochemistry (IHC) me...
The ER, PR, c erb B2 (Her2) by IHC test is a key panel used to evaluate breast cancer. It checks for three important proteins in tumor tissue such as Estrogen Receptor (ER), Progesterone Receptor (PR), and Her2 (c-erbB2) using the immunohistochemistr...
The ER, PR, c erb B2 (Her2) by IHC test is a key panel used to evaluate breast cancer. It checks for three important proteins in tumor tissue such as Estrogen Receptor (ER), Progesterone Receptor (PR), and Her2 (c-erbB2) using the immunohistochemistry (IHC) method. These markers help doctors understand the tumor's behavior. ER and PR indicate whether the cancer is hormone-sensitive and may respond to hormone-blocking treatments. Her2 is a growth-related protein, and its overexpression can signal a more aggressive c...
The ER, PR, c erb B2 (Her2) by IHC test is a key panel used to evaluate breast cancer. It checks for three important proteins in tumor tissue such as Estrogen Receptor (ER), Progesterone Receptor (PR), and Her2 (c-erbB2) using the immunohistochemistry (IHC) method. These markers help doctors understand the tumor's behavior. ER and PR indicate whether the cancer is hormone-sensitive and may respond to hormone-blocking treatments. Her2 is a growth-related protein, and its overexpression can signal a more aggressive c...
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.